Next Generation Antibodies

Next Generation Antibodies

Discover the next generation of antibodies and how biotech is driving innovation in industrial companies and academic labs for human health

By Spartners

Date and time

Monday, December 2 · 12 - 2pm CET

Location

8 Av. des Sciences

8 Avenue des Sciences 91190 Gif-sur-Yvette France

About this event

  • Event lasts 2 hours

Explore the next generation of antibodies and how biotech is transforming human health through partnerships with industrial companies and academic labs.


📅 Date: December 2nd, 2024
🕛 Time: 12:00 PM - 14:00 PM
📍 Location: Lumen – 8 Av. des Sciences, 91190 Gif-sur-Yvette


🌟 Hear from Emilia McLaughlin, CEO of Kyrion.Bio, a startup developing innovative antibody solutions to combat cancer and autoimmune diseases.

🧬 Learn from Claus Haase, Senior Vice President at Symphogen A/S - a Servier company, as he explores how industrial companies are leading innovation in developing next-generation antibodies for human health.

🔬 Bernard Maillère, Director of Research in Immunology at Université Paris-Saclay and coordinator of the ANR-funded project ACCREDIA (Accelerating Research for Early Development of Innovative Antibodies), will provide unique insights into accelerating antibody innovation through academic excellence.

🎤 The panel will be moderated by Estefania Tumbaco, a doctoral researcher at Servier, supervised by Marc Pallardy, who brings extensive experience and collaboration with Bernard Maillère—ensuring an engaging, well-informed discussion.

🤝 Networking with industry leaders: Connect with speakers, other guests and La BioTeam—a collaboration of biotech leaders from Spartners (Servier & BioLabs), Genopole, IncubAlliance, Kadans, and the Paris-Saclay Land Planning Authority.

This is a great opportunity to explore partnerships that can accelerate your biotech journey and foster innovation.

Agenda:

12:00 PM - 12:45 PM

  • Opening keynote:
    Stéphanie TEA, Investment Project Manager – Paris-Saclay Development Authority.
  • Panel Discussion (Moderated by Estefania Tumbaco):
  • Emilia McLaughlin: CEO of Kyrion.Bio.
  • Claus Haase: Senior Vice President, Symphogen A/S - a Servier company.
  • Bernard Maillère: Director of Research in Immunology, Université Paris-Saclay.

12:45 PM - 2:00 PM

  • Networking Session:
    Meet and connect with industry leaders and key actors of the Paris-Saclay cluster.

⚠️ Important Note:
Please register to secure your spot. All reservations are subject to final confirmation.

Organized by